product-launch is the sole category represented across all 1 tracked stories. U.S. Food and Drug Administration (FDA) is most often covered alongside Solius Labs, which appears in 1 of these 1 story. Each carries 2 original sources on average. We currently track 1 Startup story that mention U.S. Food and Drug Administration (FDA), all published on June 18, 2026.
Figures are computed live from our source-verified story record
— see our methodology for how impact and
sentiment are derived.
What the coverage shows about U.S. Food and Drug Administration (FDA)
product-launch is the sole category represented across all 1 tracked stories. U.S. Food and Drug Administration (FDA) is most often covered alongside Solius Labs, which appears in 1 of these 1 story. Each carries 2 original sources on average. We currently track 1 Startup story that mention U.S. Food and Drug Administration (FDA), all published on June 18, 2026.
Stories tracked
1
Sources per story
2
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 16 Startup stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Appears alongside
Other entities that clear the same relevance threshold in stories also covering U.S. Food and Drug Administration (FDA). Shared-story counts are live from our verified record — not editorial picks.
Bainbridge Island-based startup Solius Labs announces the launch of its FDA-cleared personalized sunlight device, Solius Pro, targeting the growing consumer health and wellness market. The move positions the company at the forefront of a new category of over-the-counter light therapy without prescription.
U.S. Food and Drug Administration (FDA) is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source
link? Report a data issue.